Tiangang Li to Cholesterol
This is a "connection" page, showing publications Tiangang Li has written about Cholesterol.
Connection Strength
1.260
-
Combined ASBT Inhibitor and FGF15 Treatment Improves Therapeutic Efficacy in Experimental Nonalcoholic Steatohepatitis. Cell Mol Gastroenterol Hepatol. 2021; 12(3):1001-1019.
Score: 0.648
-
An FGF15/19-TFEB regulatory loop controls hepatic cholesterol and bile acid homeostasis. Nat Commun. 2020 07 17; 11(1):3612.
Score: 0.612